IDEA4RC Adverse Event common model

IDEA4RC Cancer Episode common model

IDEA4RC Episode Event common model

IDEA4RC Genetic Test Expression common model

IDEA4RC Hospital Patient Records common model. This includes also the HospitalData model.

IDEA4RC Patient common model

IDEA4RC Patient Follow Up common model

IDEA4RC Radiotherapy common model

IDEA4RC Stage common model

IDEA4RC Surgery common model

IDEA4RC Systemic Treatment common model

IDEA4RC Treatment Response common model

It shows how the Cancer Episode model is mapped into this guide

It shows how the Episode Event model is mapped into this guide

It shows how the Genetic Test Expression model is mapped into this guide

It shows how the Hospital Patient Records model is mapped into this guide

It shows how the Patient (Subject) model is mapped into this guide

It shows how the Patient Follow up model is mapped into this guide

It shows how the Radiotherapy model is mapped into this guide

It shows how the Stage model is mapped into this guide

It shows how the Surgery model is mapped into this guide

It shows how the Systemic Treatment model is mapped into this guide

This profile constrains the Observation resource to represent alcohol use assessment for the purpose of the IDEA4RC project.

This profile constrains the Observation resource to represent Comorbidities for the purpose of the IDEA4RC project. This profiles is adapted from the mCode FHIR Implementation Guide

The Eastern Cooperative Oncology Group (ECOG) Performance Status represents the patient’s functional status and is used to determine their ability to tolerate therapies in serious illness, specifically for chemotherapy. (Definition from: LOINC)

The Karnofsky Performance Status (KPS) is a tool used to measure a patient’s functional status. It can be used to compare the effectiveness of different therapies and to help assess the prognosis of certain patients, such as those with certain cancers. The KPS score ranges from 0 to 100 in intervals of 10. Higher scores are associated with better functional status, with 100 representing no symptoms or evidence of disease, and 0 representing death.

This profile constrains the Observation resource to represent Tobacco use assessment for the purpose of the IDEA4RC project.

This profile defines how to represent Patient in FHIR for the purpose of the IDEA4RC project.

This profile defines how to represent metastatic cancer in FHIR for the purpose of the IDEA4RC project. This profile is inspired from the mCode IG. Records the history of secondary neoplasms, including location(s) and the date of onset of metastases. A secondary cancer results from the spread (metastasization) of cancer from its original site (Definition from: NCI Dictionary of Cancer Terms).

This profile defines how to represent Primary Cancer Condition in HL7 FHIR for the purpose of the IDEA4RC project. This profile is inspired from the mCode IG. A primary cancer condition, the original or first tumor in the body (Definition from: NCI Dictionary of Cancer Terms). Cancers that are not clearly secondary (i.e., of uncertain origin or behavior) should be documented as primary. This profile should be also used for documenting primary cancer relapses during or after FLT.

This profile defines how to represent diagnosis details (when the diagnosis was made; who made it;…) in FHIR for the purpose of the IDEA4RC project.

The extent of the cancer in the body, according to a given cancer staging classification system, based on evidence such as physical examination, imaging, and/or biopsy or based on pathologic analysis of a specimen.

Category describing the extent of a tumor metastasis in remote anatomical locations, based on evidence such as physical examination, imaging, and/or biopsy.

Category of the primary tumor, based on its size and extent, based on evidence such as physical examination, imaging, and/or biopsy.

Category of the presence or absence of metastases in regional lymph nodes, based on evidence such as physical examination, imaging, and/or biopsy.

This profile defines how to represent Procedures in FHIR for describing a set of Surgery data required by the IDEA4RC project. This porfiles is adapted from the PanCareSurPass Procedure Surgery profile.

This profile defines how to represent Procedures in FHIR for describing a set of Radiotherapy data required by the PanCareSurPass algorithm to generate the care plan.

This profile defines how to represent MedicationAdministration in HL7 FHIR for describing Chemotherapy data for the purpose of the IDEA4RC project.

This profile defines how to represent the Patient follow-up model and when needed the treatmement center in FHIR for the purpose of the IDEA4RC project.

This profile defines how to represent the Hospital Patient Records model in FHIR for the purpose of the IDEA4RC project.

Other Local Treatment

Pathological Report Info

This profile defines how to represent the Adverse vent model in FHIR for the purpose of the IDEA4RC project.

This profile defines how to represent a Bundle in FHIR for the purpose of the IDEA4RC project.

This profile constrains the Observation resource to represent the assertion that a cancer treatment occurred, specifying the type.

The Charlson Comorbidity Index predicts 10-year survival in patients with multiple comorbidities.

This profile constrains the Observation resource to represent the occurrence of the other cancer.

This profile constrains the Observation resource to represent Radiological Extra-nodal extension (rENE) for the purpose of the IDEA4RC project. It describes the presence or absence of radiological signs of extracapsular extension, as defined in the AJCC 8th Ed

This profile constrains the Observation resource to represent the status at the Last Follow Up.

This profile constrains the Observation resource to represent the situations where a Yes/No answer is captured for the purpose of the IDEA4RC project.

This profile constrains the Observation resource to represent the date of the last contact.

This profile constrains the Observation resource to represent test results for the purpose of the IDEA4RC project.

This profile defines how to represent Other Treatment procedures in FHIR for describing a set of Surgery data required by the IDEA4RC project. This porfiles is adapted from the PanCareSurPass Procedure Surgery profile.

Qualifier to refine an body location. These include qualifiers for relative location, directionality, number, and plane, and exclude qualifiers for laterality.

The resource has an unspecified relationship with a Condition.

Qualifier to specify laterality.

This extension allows to indicate when the procedure was performed as Timing.

This extension provides a mean to indicate the previous clinicalStatus of a condition. It might be used for example to indicate if a relapse is now in remission.

Concepts classifying the person into a named category of humans sharing common history, traits, geographical origin or nationality. Derived by the US core Race extensions.

Dose delivered to a given radiotherapy volume.

The radiation energy used for radiotherapy. The energy spectrum is characterized by the maximum energy, the maximum accelaration voltage, or the used isotope. This extension is based on the CodeX™ Radiation Therapy RadiotherapyEnergyOrIsotope extension

Extension capturing modality and technique of a given radiotherapy procedure. The allowed combinations of modality and technique are constrained by invariants, one per modality.

Extension capturing a modality of external beam or brachytherapy radiation procedures.

The number of sessions in a course of radiotherapy.

Extension capturing a technique of external beam or brachytherapy radiation procedures.

This extension is used to indicate if a relapse/progression is local, remote or combined.

This extension is temporary included in the guide for covering the request of tracking if this information has been captured and maintained by the same or other organizations. It is envisioned that this kind of requirements could be covered by recording where specific act are taking place.

Affected Organs (surgery)

Alcohol Usage Status: Athena

Alcohol Usage Status: SNOMED CT

List of WHO ATC codes for antineoplastic and immunostimulating agents.

describes the type of radiation therapy given

It describes the body site qualifier (e.g. localized)

Codes identifying codindins beloging to the Chondro Osseous Tumours group.

Codes identifying codindins beloging to the Endometrial stromal and related Tumors group.

Codes identifying codindins beloging to the Histology Adenocarcinoma group.

Codes identifying codindins beloging to the Histology Neuroendocrine group.

Codes identifying codindins beloging to the Histology Odontogenic Carcinoma group.

Codes identifying codindins beloging to the Histology SNUC group.

Codes identifying codindins beloging to the Histology Squamous group.

Codes identifying codindins beloging to the Histology Subgroup Adipocytic Tumours group.

Codes identifying codindins beloging to the Histology Subgroup Fmt Tumours group.

Codes identifying codindins beloging to the Histology Subgroup So called Fibrohistiocytic Tumours.

Codes identifying codindins beloging to the Miscellanious mesenchimal tumors group.

Codes identifying codindins beloging to the Mixed epithelial and mesenchymal tumours group.

Codes identifying codindins beloging to the Pericytic Perivascular Tumours group.

Codes identifying codindins beloging to the Peripheral Nerve Sheath Tumors group.

Codes identifying codindins beloging to the Skeletal Muscle Tumours group.

Codes identifying codindins beloging to the Smooth Muscle Tumours group.

Identifying codes based on the timing of classification for stage group observations.

Identifying codes based on the timing of classification for stage group observations.

Identifying codes based on the timing of classification for stage group observations.

Codes identifying codindins beloging to the Tumors Of Uncertain Differentiation group.

Codes identifying codindins beloging to the Vascular Tumours group.

Codes identifying the type of cancer.

Codes identifying codindins beloging to the Undifferentiated small round cell sarcomas of bone and soft tissue group.

Chemotherapy cumulative dose units

Comorbidities: Athena

Comorbidities: SNOMED CT

Current Smoking Status: Athena

Eastern Cooperative Oncology Group (ECOG) Performance Status

Type of event registered

Describes extent of extranodal extension. This number must be explicitly referred to in the pathological report, otherwise it is unknown

Gender value set based on the Athena system

Genetic Tests performed (Yes/no/Unk)

Specifies the subsite for cancers occured in hypopharynx: Athena

Specifies the subsite for cancers occured in hypopharynx: Snomed CT

Lab test results:

• EBV DNA plasma testing before treatment in NPC type II and III (WHO)
• HPV tumor testing in oral carcinoma
• C reactive protein testing.

Specifies the subsite for cancers occured in Larynx: Athena

Specifies the subsite for cancers occured in Larynx: Snomed CT

Specifies the subsite for cancers occured in lip: Athena

Specifies the subsite for cancers occured in lip: Snomed CT

margins after surgery

Specifies the subsite for cancers occured in nasal cavity and paranasal sinusess: Athena

Specifies the subsite for cancers occured in nasal cavity and paranasal sinusess: Snomed CT

Specifies the subsite for cancers occured in nasopharynx: Athena

Specifies the subsite for cancers occured in nasopharynx: Snomed CT

Not Performed/Unknown Value Set

Identifying codes based on the timing of classification for distant metastases (M) staging observations.

Identifying codes based on the timing of classification for primary tumor (T) staging observations.

Identifying codes based on the timing of classification for regional node (N) staging observations.

Occurrence of other cancer

Specifies the subsite for cancers occured in oral cavity: Athena

Specifies the subsite for cancers occured in oral cavity: Snomed CT

Specifies the subsite for cancers occured in Oropharynx: Athena

Specifies the subsite for cancers occured in Oropharynx: Snomed CT

Describes whether capsular extension is present by histopathologic examination or not

Pathological N

Pathological T (Primary Tumor)

Laboratory test results: Positive-Negative-Not tested: Athena

Laboratory test results: Positive-Negative-Not tested: Snomed CT

Race value set based on the Athena system

Radiotherapy device type this procedure is referring to. TO BE UPDATED

Clarifies the reasons why the treatment ended or was interrupted

Radiotherapy setting

Test results:

• EBV DNA plasma testing before treatment in NPC type II and III (WHO)
• HPV tumor testing in oral carcinoma
• C reactive protein testing.
• Biopsy Mitotic Count
• Tumor Size

describes the site of metastasis

Describe the primary tumor site

Derived from the HL7 LOINC value set for smoking status. Based on the HL7 Vocab and Structured Doc WG (formerly TC) consensus - per US CDC submission 7/12/2012 for smoking status terms.

Status at the Last Follow Up

Specifies the subsites where cancers occured: Athena

Specifies the subsites where cancers occured: SNOMED CT

Surgery Complication

Surgery Intention

Surgery Outcome

describes presence and grade of complications after a surgical procedure

Category of surgical procedure this resource is referring to

Types of surgical procedure this resource is referring to (to be updated)

This value set is intended to contain allowable values for the M category, according to TNM staging rules. AJCC codes (preferably, version 8 for current cancers) SHOULD be used.

This value set is intended to contain allowable values for the T category, according to TNM staging rules. AJCC codes (preferably, version 8 for current cancers) SHOULD be used.

This value set is intended to contain allowable values for the N category, according to TNM staging rules. AJCC codes (preferably, version 8 for current cancers) SHOULD be used.

Tobacco Product based on the Athena system

treatment response

Treatment Setting

It refers to the type of radiotherapy treatment delivered

refers to whether patient completed all treatment as planned or if it had to be interrupted due to several reasons

type of Diagnosis

type of systemic treatment administered

type of treatment

type of surgical approach on tumour

Types of Yes/No observations

Laboratory test results: Yes-No-Unkwnon: Athena

Temporary coded concepts to be used by this Project waiting for the assignement from international terminologies.

Genetic Test to this guide Map

Other Treatment to this guide Map

Radiotherapy Model to this guide Map

An actor dealing with head and neck cancer data.

An actor dealing with sarcoma data.